Saturday, March 18, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Biosurveillance

Germany, Italy Account for Majority of Measles Cases in EU

by Global Biodefense Staff
May 29, 2015
Toronto Investigating Multiple Cases of Measles

A 2014 case of infant measles in the Philippines. Credit: Rebecca Martin/CDC

In the past 12 months the European Union has reported 3,809 cases of measles, according the European Centre for Disease Control and Prevention (ECDC) Measles and Rubella Monitoring report.

The report also states that Germany and Italy accounted for nearly 70 percent of the cases. One measles-related death was reported during this period and six cases were complicated by acute measles encephalitis.

As of April 22, the outbreak of measles in Berlin, which has been ongoing since October 2014, has resulted in 1,134 cases. Measles cases associated with this outbreak have also been reported in Norway, France, Sweden and Croatia.

There are further ongoing measles outbreaks in Austria, Bosnia and Herzegovina, Russia, Serbia, and Kyrgyzstan as well as Mongolia, the Republic of Congo, Guinea, Liberia, Sudan, and Brazil.

High Rubella Case Count in Poland

Twenty-seven EU/EEA countries reported 4,394 rubella cases during the period April 2014 to March 2015.

Poland accounted for 96% of all reported rubella cases in the 12-month period. The highest number of cases was observed in 5–9- and 1–4-year-olds. Thirty-two percent of the cases were unvaccinated. However, this figure needs to be interpreted with caution as less than 1% of the cases were confirmed through laboratory testing.

Measles and rubella were targeted for elimination in Europe by 2015. ECDC closely monitors progress towards interruption of endemic transmission of both diseases through enhanced surveillance and epidemic intelligence.

Read the ECDC’s Measles and rubella quarterly report, April 2015.

Tags: MeaslesVaccine OppositionVaccines

Related Posts

How Are Bivalent COVID Vaccines Stacking Up Against Omicron?
Infectious Diseases

How Are Bivalent COVID Vaccines Stacking Up Against Omicron?

January 12, 2023
Officials Declare End to Ebola Outbreak in Uganda
Infectious Diseases

Officials Declare End to Ebola Outbreak in Uganda

January 11, 2023
Why Upper Respiratory Infectious are More Common in Colder Temperatures
Infectious Diseases

Why Upper Respiratory Infectious are More Common in Colder Temperatures

December 7, 2022
New Virus Discovered in Swiss Ticks
Biosurveillance

New Virus Discovered in Swiss Ticks

December 7, 2022
Load More

Latest News

Biodefense Headlines – 12 March 2023

Biodefense Headlines – 12 March 2023

March 12, 2023
Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
Biodefense Headlines – 24 January 2023

Biodefense Headlines – 24 January 2023

January 24, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC